ReportWire

Tag: pills

  • Florida Law and Order Priorities Highlighted by Governor DeSantis, AG Moody, Sheriff Judd

    Florida Law and Order Priorities Highlighted by Governor DeSantis, AG Moody, Sheriff Judd

    [ad_1]

    Florida Governor Ron DeSantis highlighted law and order priorities, including protecting from fentanyl and illegal drugs, and curbing illegal immigration, with Attorney General Ashley Moody, Sheriff Grady Judd, and others in law enforcement.

    Last year, Governor DeSantis signed legislation establishing the State Assistance for Fentanyl Eradication (SAFE) grant program, which provides law enforcement with the funding needed to conduct large-scale drug operations across the state, including many in Central Florida.

    Florida has also enacted a suite of legislation to crack down on crime, curb illegal immigration, increase penalties for drug and human traffickers, and recruit law enforcement officers to the state.

    And when two state attorneys refused to carry out the duties of their positions and enforce the law, Governor DeSantis removed them from office.

    “Leadership matters,” said Republican Governor Ron DeSantis. “Law and order is maintained when leaders insist on enforcing the law. Florida has enacted legislation to combat crime, recruited police officers from all over the country, refused to allow cities to defund the police, and—when necessary—removed rogue state attorneys who refused to enforce the law.”

    “Florida is a law-and-order state, and through proactive leadership and diligent law enforcement efforts we continue to prosper, break tourism records and lead in new business formations,” said Attorney General Ashley Moody. “This is due in large part to the brave men and women in law enforcement, and we will always work to ensure they are supported by Florida leadership.”

    In 2023, the Governor approved $20 million in funding for Florida’s SAFE program administered by the Florida Department of Law Enforcement. This state-funded grant has allowed local law enforcement agencies to effectively fight against drug trafficking and get hundreds of pounds of deadly drugs off our streets.

    “I commend Governor DeSantis and the Florida legislature for their support of law enforcement in Florida,” said Polk County Sheriff Grady Judd. “We are a law and order state, and proud of it. Because of this, our communities are thriving. Florida is a safe place to live, work, and play.”

    Examples of Florida being a law and order state from SAFE grant success stories include:

    • In January 2024, the Polk County Sheriffs Office utilized SAFE to arrest 11 suspects trafficking in fentanyl and cocaine, seizing 30 pounds of cocaine and nearly 8 pounds of fentanyl.
    • In March 2024, Santa Rosa County and Escambia County Sheriffs’ offices, working alongside the DEA, seized 3 grams of fentanyl, marijuana, prescription pills, and several handguns.
    • In April 2024, FDLE operations in conjunction with Sheriffs’ Offices in Seminole County and Palm Beach County resulted in arrests of nearly 40 drug traffickers.
    • In April 2024, officers in the Fort Myers region successfully seized nearly 4kg of cocaine, 90g of fentanyl, 69g of MDMA, 375g of marijuana, two AR-15 weapons, and more than $60,000 in currency.
    • In July 2024, FDLE Pensacola, Santa Rosa County and Okaloosa County Sheriff’s offices, Fort Walton Beach Police Department, FHP, and the DEA announced the arrest of 19 drug traffickers facing charges including trafficking in cocaine, methamphetamine, fentanyl, conspiracy to distribute, and racketeering.
    • In August 2024, a SAFE-funded investigation dismantled a drug trafficking operation in St. Petersburg which was responsible for manufacturing hundreds of doses of fentanyl daily throughout Polk County, specifically in Lakeland.
      • Officers confiscated 10.7 kilos of fentanyl, along with cocaine, oxycodone, marijuana, 3 illegal firearms, and over $500,000 in cash.

    “Florida is a national model in eradicating drugs from our communities and taking criminals off the street,” said Florida Highway Safety and Motor Vehicles Executive Director Dave Kerner. “In every corner of this great state, you will find State Troopers and local law enforcement working together to interdict drugs and arrest those who profit off of it. Instead of being demonized, Governor DeSantis celebrates the dangerous work our law enforcement officers do every day, and our men and women in law enforcement deeply appreciate that.”

    In total, SAFE funds have resulted in over 650 arrests and the seizure of more than 145 pounds of fentanyl, 220 pounds of cocaine, and 60,000 fentanyl pills – numbers officials say show Florida is a law and order state.

    “Thanks to Governor Ron DeSantis and his leadership, Florida’s law enforcement officers have arrested hundreds of dangerous drug traffickers and taken fentanyl and other deadly drugs off our streets,” said Florida Department of Law Enforcement Commissioner Mark Glass. “Florida is a national role model and stands in stark contrast to crime-plagued blue states.”

    [ad_2]

    Source link

  • Drug Maker Recalls ADHD Medicine Over Label Mixup | High Times

    Drug Maker Recalls ADHD Medicine Over Label Mixup | High Times

    [ad_1]

    The U.S. Food and Drug Administration last week announced the voluntary recall of a medicine used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy after the manufacturer of the drug revealed that the wrong pills were found in packages of the medication. The recall covers one lot of the drug Zenzedi, an ADHD and narcolepsy medication manufactured by Massachusetts-based Azurity Pharmaceuticals.

    In a notice about the recall, the FDA noted that a pharmacist had reported finding pills of an antihistamine, carbinoxamine maleate, in a package of Zenzedi. The voluntary recall was announced by Azurity on January 24 and covers packages of Zenzedi 30 milligram tablets with lot number F230169A and an expiration date of June 2025.

    The recalled medication was distributed nationwide through retail pharmacies. Pharmacies and drug wholesalers have reportedly pulled the drug from their shelves to comply with the recall. Customers who purchased packages of the recalled lot of Zenzedi are urged to return any remaining pills to the place of purchase. Patients who take the mislabeled medication and have adverse reactions are encouraged to see their doctor. 

    Drugs Have Opposite Effects

    The two drugs have opposite effects when taken, according to a report from CBS News. Carbinoxamine maleate is an antihistamine that is used to treat allergies and has a sedative effect on some patients, while Zenzedi, a brand name for the drug dextroamphetamine sulfate,  is a stimulant that generally increases a patient’s attentiveness. Zenzedi is used to treat narcolepsy, a sleep disorder that causes overwhelming daytime drowsiness, and ADHD.

    The FDA added that patients who take carbinoxamine maleate instead of Zenzedi will experience undertreatment of their symptoms. Patients can also have a potentially deadly elevated risk of accidents or injuries and may have drowsiness, increased eye pressure, urinary obstruction and thyroid disorder, among other symptoms, according to the FDA’s recall notice.                                           

    “Patients who take carbinoxamine instead of Zenzedi® will experience undertreatment of their symptoms, which may result in functional impairment and an increased risk of accidents or injury,” the FDA wrote in a notice about the recall. “Patients who unknowingly consume carbinoxamine could experience adverse events which include, but are not limited to, drowsiness, sleepiness, central nervous system (CNS) depression, increased eye pressure, enlarged prostate urinary obstruction, and thyroid disorder.”

    Azurity Pharmaceuticals sent recall notification letters to drug wholesalers on January 4 via an overnight letter and has arranged for the return of all affected product at the wholesale level. The company said that no reports of serious injury have been made as a result of the mixup.   

    Recall Comes During Shortage of ADHD Meds

    The Zenzedi recall comes in the midst of a nationwide shortage of medications used to treat ADHD. The shortage has been affecting supplies of the drug Adderall since a manufacturer experienced production delays in Fall 2022, according to a report from CNN.

    At least 11 manufacturers of Adderall or generic versions of the drug were listed on the FDA’s shortage list in September 2023. The shortage of ADHD medication has left many patients struggling to fill their prescriptions, according to healthcare professionals. 

    “A lot of the young people that I’ve been treating have had difficulties getting their medications month to month,” Dr. Warren Ng, a professor of psychiatry at Columbia University Medical Center who also serves as president for the American Academy of Child and Adolescent Psychiatry, told CNN.

    When taking their prescribed medication, many patients with ADHD are able to function better. But when they run out of their medication, it can have a tremendous impact on their self-esteem.

    “I’ve seen kids who want to drop out of school, don’t want to continue with their educational path or drop out of college suddenly making the honor roll,” Ng said. And “instead of seeing, being seen as being lazy or dumb or slow, they can envision themselves really utilizing all of their mental, psychological and intellectual abilities to really see themselves for who they are, which is so much more.”

    [ad_2]

    A.J. Herrington

    Source link

  • Drug Makers Struggle to Replace Stimulants with Non-Addictive Alternatives | High Times

    Drug Makers Struggle to Replace Stimulants with Non-Addictive Alternatives | High Times

    [ad_1]

    Unfortunately, the same drugs with high potential for abuse are also the ones that work best for certain individuals with neurobehavioral conditions. According to GlobalData, penetrating the stimulant-dominated pharmaceutical market remains challenging without comparable efficacy from non-stimulants. 

    The attention deficit hyperactivity disorder (ADHD) market is a lucrative business: Stimulants, amphetamines, and methylphenidates continue to dominate the ADHD drug market across the seven major markets, Express Pharma reports. (The seven major markets are in France, Germany, Italy, Spain, the UK, the US, and Japan.)

    Non-addictive drugs demonstrate a “crippling lower” efficacy in treating ADHD.

    Drug makers are in a race to develop safer alternatives. Three out of the four late-stage pipeline drug candidates in Phase III development within those markets have non-stimulant properties: Axsome Therapeutics Inc’s solriamfetol, Otsuka Pharmaceutical Co Ltd’s centanafadine and Neurocentria Inc’s L-Threonate Magnesium Salt. 

    The lower abuse potential of solriamfetol and centanafadine is a major selling point created by developers, but without displaying efficacy comparable to stimulants, they will struggle to penetrate the market—even if they are approved.

    The use of stimulants for ADHD treatment is increasing.

    The key opinion leaders (KOLs) in the treatment of ADHD say that patients and parents have been hesitant to use stimulants for the treatment of ADHD in children and adolescents, but this is changing with time, and the use of stimulants for ADHD treatment is increasing.

    “Marketing emphasis on abuse potential is common in non-stimulates both marketed and pipeline; this is despite KOLs viewing the abuse potential of ADHD stimulants as overstated,” said Lorraine Palmer, Pharma Analyst at GlobalData. “The KOLs interviewed by GlobalData were not concerned about whether a treatment is a stimulant or a non-stimulant, rather they are focused on the pharmaceuticals efficacy and side-effect profile.”

    Four non-stimulants are commonly marketed: guanfacine, clonidine, atomoxetine and viloxazine. Sleep disturbances and a decreased appetite have been reported from both clonidine and atomoxetine. 

    “All four display cripplingly lower efficacy in the treatment of ADHD than stimulants,” Express Pharma reports.

    “Rather than an emphasis on abuse potential, a better alternative strategy to penetrate the saturated ADHD market would be to target key unmet needs in ADHD treatment such as improving compliance or providing coverage into the evening without affecting sleep.”

    Part of this challenge likely includes the impact of addiction itself.  Regarding the popular ADHD drug Adderall, adults and children 6 years of age and older are eligible to take Adderall, beginning at 5 milligrams, while children 3 to 5 years of age are able to start at 2.5 mg per day. Only children under the age of 3 are prohibited from being prescribed the drug in all cases.

    Adderall’s active ingredients are dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate. Columbia University psychiatry professor Carl Hart famously wrote for Vice in 2016 that meth is “almost identical to Adderall” in terms of chemistry and its effects on the brain.

    A 2016 study published in the Journal of Clinical Psychiatry indicates that an increasing number of young adults have been checking into emergency rooms over the past few years due to accidental overdoses on Adderall and similar drugs.

    Other Reasons for Stimulant Alternatives

    High Times reported last September that leading drug makers and pharmaceutical companies are having little luck addressing nationwide shortages of stimulant-based ADHD medications like Adderall, Vyvanse, and Ritalin.

    The Adderall shortage began in Fall of 2022, marked by an FDA notice acknowledging the shortages with an estimate that things would be resolved in a month or two. That is not the case, however, as issued a joint notice on August 1 acknowledging that the shortage had been “understandably frustrating” for patients and providers.

    “The current shortage of stimulant medications is the result of many factors. It began last fall due to a manufacturing delay experienced by one drug maker,” the joint notice said. “While this delay has since resolved, we are continuing to experience its effects in combination with record-high prescription rates of stimulant medications. Data show that, from 2012 to 2021, overall dispensing of stimulants (including amphetamine products and other stimulants) increased by 45.5 percent in the United States.” 

    Teva Pharmaceuticals, Adderall’s biggest manufacturer, reported shortfalls. Teva CEO Richard Francis told Bloomberg that the company is operating at “full capacity” at the moment and blamed their decreased output in previous years to COVID-induced work shortages which they have only just barely recovered from. Should they wish to increase the amount of Adderall they produce, they would have to buy or build more factories as their current infrastructure cannot handle bigger output. The company has declined to comment on whether or not they plan to invest in such infrastructure.

    This adds to the multiple reasons less addictive non-stimulant drugs are needed to treat ADHD.

    [ad_2]

    Benjamin M. Adams

    Source link

  • Birth Control Isn’t the Only Thing That Just Went Over-the-Counter

    Birth Control Isn’t the Only Thing That Just Went Over-the-Counter

    [ad_1]

    The FDA announced yesterday that it had for the first time approved a daily birth-control pill for over-the-counter sales. That’s a big change; once the product, called Opill, is on the market—which may be as soon as early 2024—Americans will be able to buy daily hormonal birth control without a prescription. That’s historic news, but hidden underneath it is another set of firsts: In the coming months, Americans will also be able to grab an over-the-counter treatment for their heavy periods, cramps, headaches, and even migraines; they’ll have prescription-free access to a drug for endometriosis and polycystic ovary syndrome; and they’ll be able to buy a medication that can mitigate the symptoms of menopause. It’s all in the same, progestin-based pill.

    The FDA’s approval only covers Opill’s use as a form of birth control, but doctors have been prescribing pills that contain progestin for noncontraceptive needs for years. For the most part, the intervention works much better when the pills include both progestin and estrogen. Adding that second hormone to the mix amplifies all of progestin’s beneficial effects, plus helps control hormonal acne. It also leaves more wiggle room in terms of timing: Progestin-only pills—sometimes called a minipill—have a much shorter half-life in the body, so if you don’t take them during the same three-hour window each day, they’re much less reliable at preventing pregnancy, says Anne-Marie Amies Oelschlager, the chief of pediatric and adolescent gynecology at Seattle Children’s. (Some women are prescribed progestin-only pills because they are particularly susceptible to certain risks associated with estrogen.)

    As a result, an over-the-counter progestin-only pill is far from the best way of treating these conditions, experts told me. “While I suppose that it could be used off-label, I would be hesitant to do that if someone was otherwise able to obtain a prescription for a combined oral contraceptive,” Erin Fleurant, a family-planning fellow at Northwestern Medicine, told me. And if progestin by itself really were the right approach, then an IUD, implant, or injection might be a more effective way to deliver the drug.

    Despite the fact that progestin on its own would not usually be a doctor’s first choice—“I generally don’t prescribe it,” Veronica Ades, the vice chair of ob/gyn at Jacobi Medical Center, told me—the drug can have meaningful benefits when taken on its own. Amies Oelschlager told me that she prescribes it to suppress patients’ periods, especially if they’re experiencing pain or heavy bleeding. Even low-dose pills (like Opill) can be helpful for controlling period- and perimenopause-related migraines, as well as mood swings from premenstrual syndrome or premenstrual dysphoric disorder.

    Progestin pills can also be used to treat endometrial hyperplasia, an abnormal thickening of the uterine lining (a.k.a. the endometrium) that can develop into cancer. Same for endometriosis, a condition that may affect up to 11 percent of American women in which endometrial tissue grows outside the uterus. Patients with PCOS produce unusually high levels of male sex hormones and, Ades said, generally have too much estrogen in their body relative to progesterone (the naturally occurring analogue of progestin). Progestin pills can help strike a healthier balance.

    Right now, patients have few options to get relief from any of those symptoms without a doctor’s help. Until Opill hits the market, the best non-prescription way to treat PCOS is with healthy eating and exercise, Amies Oelschlager told me. For heavy periods, the best option patients can buy without a prescription is an NSAID like ibuprofen. “As far as an over-the-counter, daily hormonal medication, this is the first in the United States,” she said.

    Perhaps the best circumstances for off-label use of Opill will be as a stopgap. If someone starts having abnormal bleeding or period pain but can’t get an appointment or travel to a doctor for several weeks, they could buy themselves some progestin-only pills for the interim. Opill could also be a backup plan for patients who are already taking birth-control pills for a non-birth-control purpose but can’t make it to their doctor to renew their prescription, or can’t get their prescription filled at a pharmacy.

    Still, Ades cautioned that even stopgap use might not be wise for endometriosis patients, for whom switching medications could disrupt a delicate balance of hormones and “create a cascade of problems.” Fleurant warned that some of the symptoms that progestin pills could help alleviate may also be associated with very serious conditions that need a different treatment plan. “Say someone was 45 years old and having irregular bleeding and also had a lot of other risk factors for uterine cancer. I wouldn’t want them to pick up this pill and think that that was going to cure everything,” she said. Instead, they should be seen by a health-care provider.

    For most women who need to be on birth control, a single-hormone drug like Opill is not the most reliable option; but starting next year, it could well be the most convenient. That same trade-off, between effectiveness and access, affects other uses of progestin, too.

    [ad_2]

    Rachel Gutman-Wei

    Source link

  • No One in Movies Knows How to Swallow a Pill

    No One in Movies Knows How to Swallow a Pill

    [ad_1]

    There are two ways of taking pills—two and only two.

    You pinch the pill between your thumb and index finger, pick it up, and place it on your tongue. You take a drink of water. This method is the tweezers.

    Or else: You place the pill in your palm and launch it toward your mouth, as if your teeth were battlements and your arm a siege machine. Don’t bother with the water. This method is the catapult.

    In real-world situations, many people—let’s say most—make a habit of the tweezers. In the movies, the opposite is true. An on-screen pill bottle works like Chekhov’s gun: Eventually, its contents will be fired at an actor’s mouth, or smashed between his lips, or hurled into his gullet.

    Think of Austin Butler as the lead in Elvis, alone in his hotel room: He slaps those quaaludes in, liquid-free, sideburns tilted toward the ceiling. It’s a textbook movie swallow, the Stanislavski Fling. Butler got an Oscar nomination; so did Ellen Burstyn, popping diet pills in Requiem for a Dream. On Succession, Jeremy Strong and Kieran Culkin, each a two-time Emmy nominee, gobble meds on-screen. Going catapult is everywhere in cinema; it’s a gesture that befits the biggest stars. Angelina Jolie shoots her pills in Girl, Interrupted. So does Brittany Murphy. Jake Gyllenhaal catapults a pill in Donnie Darko. Albert Brooks in Modern Romance. In Goodfellas, Ray Liotta does it twice.

    I love the movies! But it’s time we had a public-health announcement: The catapult is not, in fact, how a person should be taking pills. The act of swallowing a medication is so pervasive—and so intimate—that one easily forgets it is a skill that must be learned. In the U.S., roughly three-fifths of all adults are on prescription drugs; perhaps one-sixth will falter when they try to gulp it down. Twenty years ago, Bonnie Kaplan, a research psychologist at the University of Calgary, devised a new technique for helping people overcome this problem. Her method, as laid out in a mesmerizing video, suggests that you turn your head to make a pill go in. (No one has ever done this in a movie and no one ever will.) The turning motion helps open your upper esophageal sphincter, Kaplan says, though she does admit that more familiar postures have their own advantages. Some people like to raise their chins: “They say it is easier for the pill to slide down their throat, as if their tongue is a ski jump and it is a straight shot down the hill.” Others tip their heads the other way, chin-to-chest, “because they say it is more relaxing in the neck.”

    But on the all-important matter of the hand, Kaplan’s messaging is very clear: You pick up the pill between your fingers; then you place it on your tongue. Which is to say, you do the tweezers. Other training methods are consistent with this rule. One approach for teaching children, published in 1984, describes “correctly placing” a pill on the back of the tongue—which clearly cannot be accomplished via a whole-hand toss; another, from 2006, says to “place the pill on your tongue towards the back of your mouth.”

    That’s how people ought to take their pills. But how do people really do it, in real life? At the start of her research, Kaplan told me, she wasn’t telling takers what to do; she spent time observing how they liked to swallow medications on their own. The cinematic catapult was simply nonexistent in the wild, she said. “I never saw anyone just throw it back.” Never? Anyone? I asked Kaplan to describe the way she swallows pills herself, and she paused before she answered, as if she’d never really thought this through. “My husband and I both turn our heads to the right,” she said at last. First she’ll place the pill on the back of her tongue, and then she’ll twist and swallow. “But you know what?” she said. “I do often clap my hand to my mouth with my last pill or two.”

    “It’s very individual,” Cindy Corbett, a nursing-science professor at the University of South Carolina, told me. She’s on a team that uses smartwatch accelerometers to track patients’ adherence to their medication regimen. Their system knows when someone moves a hand up to their face, she told me, but it won’t distinguish how a pill is being held, or whether it is placed or flung into the mouth. (Indeed, the study’s four-step “protocol-guided medication-taking activity” includes this ambivalent instruction: “Place/toss pill to mouth.”) When I asked Corbett what she’s seen herself in this regard, as a clinician, she drew a blank. “I’ve never thought about it that much.”

    Maybe this is it: If you even have to think about the way you swallow pills, then you’re almost certainly someone who has trouble taking pills; and if you’re someone who has trouble taking pills, then you really should be taking pills in tweezer mode. In the off-screen world, to catapult is a privilege reserved for those with floppy throats. It’s the difference between the gags and the gag-nots. That inequality is only reinforced by the movieland fantasy of universal tossing, which sets up (as only Hollywood knows how) an impossible and unhealthy standard for behavior. Look, Elvis gobbles benzos; why can’t I? “People’s preconceived notions of how they’re supposed to swallow pills does lead to mental barriers,” says Marissa Harkness, a co-creator of the Pill Skills training kit, a case of sugar-based placebos made in different shapes and sizes.

    When actors catapult on camera, they get the benefit of looking more dramatic: bigger gestures, more to see. But something more important is going on in movie swallows, a deeper meaning to the movement—an implied relationship of power. Taking pills by catapult suggests that you’re a victim, that your body and your mind are under siege. A hand that’s driven by compulsion fires drugs into the face. A teenage boy is pelted by his Prozac. But some stories need to have this flipped, so the pill can be a tool instead of an affliction. In Taxi Driver, Robert De Niro tweezers bennies. He’s a man on a mission. And the most famous pill-taking scene in movie history, from The Matrix, has Keanu Reeves pinch a pill between his thumb and index fingers in dramatic close-up, and deposit it into his mouth. Then he drinks a glass of water. (Is that a movie first?) A character who tweezers is going on a journey, the film director John Magary told me. He’s curious. He’s in control. (From Magary’s films to date: two catapults, zero tweezers.)

    Perhaps the movies have this figured out. There are two ways of taking pills—two and only two. The tweezers or the catapult; self-knowledge or oblivion. In the end, the choice is yours.

    [ad_2]

    Daniel Engber

    Source link

  • Local controlled substance expert warning of rainbow fentanyl pills

    Local controlled substance expert warning of rainbow fentanyl pills

    [ad_1]

    The Drug Enforcement Administration is sending out a warning about rainbow-colored pills laced with potent amounts of fentanyl. Now, WISN 12 News is hearing from a local doctor urging parents and users to be aware.This week, federal agents in New York City seized thousands of pills found in a Lego box. Those pills are laced with fentanyl, a highly-addictive and deadly synthetic opioid.Those pills originated on the West Coast, but are now all over the country, including in the Milwaukee area.Dr. Diana Bottari is the medical director of the Controlled Substance Monitoring Team for Advocate Aurora Health. She said these pills are not just an issue in New York or Chicago, but all over the country.She has this warning for parents.”It is something to worry about. The best thing we can do is talk to kids and let them know one use can be their last use. You cannot taste it, you cannot see it, you cannot smell it,” Bottari said.Bottari also said the amount of fentanyl can be as small as a grain of salt to be lethal.Milwaukee police also say they have recovered the rainbow pills locally.If you or someone you know is battling addiction, help is available through Aurora Health. Call 414-414-454-6600.

    The Drug Enforcement Administration is sending out a warning about rainbow-colored pills laced with potent amounts of fentanyl. Now, WISN 12 News is hearing from a local doctor urging parents and users to be aware.

    This week, federal agents in New York City seized thousands of pills found in a Lego box. Those pills are laced with fentanyl, a highly-addictive and deadly synthetic opioid.

    Those pills originated on the West Coast, but are now all over the country, including in the Milwaukee area.

    Dr. Diana Bottari is the medical director of the Controlled Substance Monitoring Team for Advocate Aurora Health. She said these pills are not just an issue in New York or Chicago, but all over the country.

    She has this warning for parents.

    “It is something to worry about. The best thing we can do is talk to kids and let them know one use can be their last use. You cannot taste it, you cannot see it, you cannot smell it,” Bottari said.

    Bottari also said the amount of fentanyl can be as small as a grain of salt to be lethal.

    Milwaukee police also say they have recovered the rainbow pills locally.

    If you or someone you know is battling addiction, help is available through Aurora Health. Call 414-414-454-6600.

    [ad_2]

    Source link